Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  2002-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/RCCM.2108086PMID 12204859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adult familial cryptogenic fibrosing alveolitis in the United Kingdom

  2000cited by this paper
• Captopril increased mitochondrial coenzyme Q10 level, improved respiratory chain function and energy production in the left ventricle in rabbits with smoke mitochondrial cardiomyopathy

  1999cited by this paper
• Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease.

  1999cited by this paper
• Angiotensin II induces apoptosis in human and rat alveolar epithelial cells.

  1999cited by this paper
• Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.

  1999cited by this paper
• Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training.

  1999cited by this paper
• Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides.

  1999cited by this paper
• Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages.

  1999cited by this paper
• A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group.

  1998cited by this paper
• Pulmonary edema induced by angiotensin I in rats.

  1998cited by this paper
• Cellular carboxypeptidases

  1998cited by this paper
• Kinetic alterations of angiotensin-II and nitric oxide in radiation pulmonary fibrosis.

  1998cited by this paper
• Measured haplotype analysis of the angiotensin-I converting enzyme gene.

  1998cited by this paper
• A Randomized Controlled Trial of Filgrastim as an Adjunct to Antibiotics for Treatment of Hospitalized Patients with Community-Acquired Pneumonia

  1998cited by this paper
• Reversal of early metabolic dysfunction in hypertensive rat left-ventricular myocytes by angiotensin-converting enzyme inhibition.

  1997cited by this paper
• Inhaled nitric oxide does not change transpulmonary angiotensin II formation in patients with acute respiratory distress syndrome.

  1997cited by this paper
• Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale.

  1997cited by this paper
• Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis.

  1997cited by this paper
• High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma.

  1997cited by this paper
• Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance.

  1997cited by this paper
• Angiotensin II-induced pulmonary edema in a rabbit model.

  1997cited by this paper
• Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans.

  1996cited by this paper
• Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis.

  1996cited by this paper
• Potential Role of Bradykinin in Forearm Muscle Metabolism in Humans

  1996cited by this paper
• Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin‐Converting Enzyme

  1995cited by this paper
• Identification of polymorphic sites of the human bradykinin B2 receptor gene.

  1995cited by this paper
• Pulmonary edema induced by angiotensin II in rats.

  1995cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper
• Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.

  1994cited by this paper
• Linkage of the angiotensinogen gene to essential hypertension.

  1994cited by this paper
• A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study.

  1993cited by this paper
• A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

  1993cited by this paper
• Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.

  1993cited by this paper
• Angiotensin-1-converting enzyme activity as index of pulmonary damage in thermal injury with or without smoke inhalation.

  1992cited by this paper
• Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.

  1992cited by this paper
• Captopril reduces collagen and mast cell accumulation in irradiated rat lung.

  1990cited by this paper
• An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

  1990cited by this paper
• Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

  1988cited by this paper
• Angiotensin converting enzyme in bronchoalveolar lavage in ARDS.

  1987cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS.

  1985cited by this paper
• Monocrotaline-Induced Pulmonary Fibrosis in Rats: Amelioration by Captopril and Penicillamine

  1985cited by this paper
• APACHE II: a severity of disease classification system.

  1985cited by this paper
• Pulmonary angiotensin II production in respiratory failure.

  1983cited by this paper
• Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.

  1977cited by this paper

• Ischaemic heart disease is the factor associated with severe COVID-19 in the urban population of Uzbekistan: a single‑center retrospective study.

  2026cites this paper
• The Distribution of Sport Performance Gene Variations Through COVID-19 Disease Severity

  2025cites this paper
• Restoring lung renin-angiotensin system balance through blood pressure control.

  2025cites this paper
• Monocrotaline treatment of the rat predisposes to altered lipopolysaccharide-induced lung responses

  2025cites this paper
• Revisiting the monocrotaline‐treated rat as a model of inflammatory lung disease: COVID‐19 and future pandemic threats?

  2025cites this paper
• The Association Between ACE I/D and ACE2 rs2285666 Polymorphisms with COVID-19 Disease Severity

  2025cites this paper
• Gene Polymorphism Associated With Acute Respiratory Distress Syndrome (Ards): A Literature Review

  2025cites this paper
• Learning from living: chance, curiosity and colleagues

  2024cites this paper
• The Association Between Genetic Variants in ACE1and ACE2 Genes with Susceptibility to COVID-19 Infection

  2024cites this paper
• Association of IL-10–592 C > A /-1082 A > G and the TNFα -308 G > A with susceptibility to COVID-19 and clinical outcomes

  2024cites this paper
• The Relation between ACE Gene Polymorphism and the Severity of COVID-19 Infection

  2023cites this paper
• Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection

  2023cites this paper
• ACE2 ve TMPRSS2 Genlerinin Farklı Hücre Hatlarındaki İfade Düzeyleri

  2023cites this paper
• Association of the ACE and AGT gene polymorphisms with global disparities in COVID-19-related deaths

  2023cites this paper
• Potential Impact of Subphenotyping in Pharmacologic Management of Acute Respiratory Distress Syndrome

  2023cites this paper
• Cancer patients with Angiotensin-converting enzyme (ACE) gene polymorphism and COVID-19 phenotypic expression predisposed to SARS-CoV-2 infection

  2023cites this paper
• The Effect of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on the Severity and Death Rate of COVID-19 in Iranian Patients

  2023influential citation
• Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of COVID-19: A Meta-Analysis

  2023cites this paper
• Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis

  2022cites this paper
• Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID‐19 patients with varying severity of lung involvement and its effect on serum cytokines levels

  2022cites this paper
• Angiotensin-converting enzyme 1 and voltage-gated potassium channel-interacting protein 4 gene polymorphisms in COVID-19 patients from east of Iran

  2022cites this paper
• The impact of COVID-19 on populations living at high altitude: Role of hypoxia-inducible factors (HIFs) signaling pathway in SARS-CoV-2 infection and replication

  2022cites this paper
• Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease

  2022influential citation
• The interacting physiology of COVID‐19 and the renin‐angiotensin‐aldosterone system: Key agents for treatment

  2022cites this paper
• An Introduction to the Pathogenetic Mechanisms of CoViD19 Complications

  2022cites this paper
• Unilateral pulmonary edema associated factors after minimally invasive mitral valve surgery.

  2022cites this paper
• The association of angiotensin-converting enzyme gene polymorphism with respiratory distress syndrome in premature neonates.

  2022cites this paper
• Evolution of multiple omics approaches to define pathophysiology of pediatric acute respiratory distress syndrome

  2022cites this paper
• Association of ACE gene polymorphisms with cardiovascular events in patients after elective percutaneous coronary interventions

  2022cites this paper
• An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection

  2022cites this paper
• Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease

  2022cites this paper
• The role of angiotensin I converting enzyme insertion/deletion polymorphism in the severity and outcomes of COVID-19 patients

  2022cites this paper
• Morphological and functional findings in COVID-19 lung disease as compared to Pneumonia, ARDS, and High-Altitude Pulmonary Edema

  2022cites this paper
• Genetics of COVID‐19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review

  2022cites this paper
• Effect of heated tobacco products and traditional cigarettes on pulmonary toxicity and SARS-CoV-2-induced lung injury

  2022cites this paper
• [Role of ACE2 in COVID-19].

  2022cites this paper
• ACE DD polymorphism in severe COVID-19

  2021cites this paper
• Puerarin exhibits antiinflammatory properties in gunpowder smog-induced acute lung injury in rats via regulation of the renin-angiotensin system and the NFκB signaling pathway

  2021cites this paper
• Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19

  2021cites this paper
• A Tale of Two Hearts: Cardiac Manifestations of Coronavirus-2019. A Case Series and Literature Review

  2021cites this paper
• Alu retrotransposons and COVID-19 susceptibility and morbidity

  2021cites this paper
• ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19

  2021cites this paper
• Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study

  2021cites this paper
• A tale of two diseases: Sarcoidosis, COVID-19 and new therapeutic options with dual RAS inhibition and tetanus-diphtheria vaccine

  2021cites this paper
• Angiotensin–Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID-19 Symptoms

  2021influential citation
• Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic

  2021cites this paper
• Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection

  2021cites this paper
• The Stress of COVID-19: Playing Havoc with the Hormones-A Review

  2021influential citation
• The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019

  2021cites this paper
• Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality

  2021cites this paper
• Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †

  2021cites this paper
• A Potential Role of the Renin-Angiotensin-System for Disturbances of Respiratory Chemosensitivity in Acute Respiratory Distress Syndrome and Severe Acute Respiratory Syndrome

  2021cites this paper
• Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)

  2021influential citation
• The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19

  2021cites this paper
• SARS-CoV-2-IgG Response and the Role of ACE2 G8790A and ACE I/D Polymorphic Variants as Determinants of Covid-19 Severity-A Genetic Association Study in north Indian Population

  2021cites this paper
• The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department

  2021cites this paper
• Factores asociados al edema pulmonar unilateral después de la cirugía mínimamente invasiva de la válvula mitral

  2021cites this paper
• Genetics of Acute Respiratory Distress Syndrome: Pathways to Precision.

  2021cites this paper
• ACE Gene I/D Polymorphism and Acute Pulmonary Embolism in COVID19 Pneumonia: A Potential Predisposing Role

  2021cites this paper
• COVID-19: A Redox Disease—What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About Its Treatment

  2021cites this paper
• Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury

  2021cites this paper
• Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19

  2021influential citation
• COVID-19 and Renin Angiotensin Aldosterone System: A Pharmacogenomic View.

  2021cites this paper
• The assessment of serum ACE activity in COVID-19 and its association with clinical features and severity of the disease

  2021influential citation
• Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention

  2021cites this paper
• COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

  2020cites this paper
• A look into Possible New Treatment Modality for COVID 19: ACE 2

  2020cites this paper
• COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

  2020cites this paper
• Acute Respiratory Distress Syndrome: Etiology, Pathogenesis, and Summary on Management

  2020cites this paper
• Are Migraine Patients at Increased Risk for Symptomatic Coronavirus Disease 2019 Due to Shared Comorbidities?

  2020cites this paper
• SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype

  2020cites this paper
• ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19

  2020cites this paper
• A dissection of SARS-CoV2 with clinical implications (Review)

  2020cites this paper
• Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities

  2020cites this paper
• Worldwide ACE (I/D) polymorphism may affect COVID-19 recovery rate: an ecological meta-regression

  2020cites this paper
• Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study

  2020cites this paper
• The Renin-Angiotensin-Aldosterone System in Coronavirus-19 Disease Pathogenesis: Extracting the Devil in the Details.

  2020cites this paper
• ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives

  2020cites this paper
• Pathophysiology and pharmacological management of pulmonary and cardiovascular features of COVID-19

  2020influential citation
• Geographic components of SARS-CoV-2 expansion: a hypothesis

  2020cites this paper
• The renin–angiotensin–aldosterone system as a link between obesity and coronavirus disease 2019 severity

  2020cites this paper
• Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?

  2020cites this paper
• Why the Use of Angiotensin II May Be a Fatal Mistake in Covid-19

  2020cites this paper
• Supplementation with vitamin D in the COVID-19 pandemic?

  2020cites this paper
• Uso terapéutico de los inhibidores de la enzima convertidora de angiotensina en pacientes con COVID-19: las «dos caras de la moneda»

  2020cites this paper
• IL-6 in inflammation, autoimmunity and cancer

  2020influential citation
• Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019

  2020cites this paper
• COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?

  2020cites this paper
• Identifying pathophysiological bases of disease in COVID-19

  2020cites this paper
• Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19

  2020cites this paper
• Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers

  2020cites this paper
• Endothelial Damage in Acute Respiratory Distress Syndrome

  2020cites this paper
• Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19

  2020cites this paper
• ACE polymorphisms and COVID-19-related mortality in Europe

  2020cites this paper
• Clinical population genetic analysis of variants in the SARS-CoV-2 receptor ACE2

  2020cites this paper
• Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis

  2020cites this paper
• Corona Virus (SARS-COV-2) Induced Inflammatory Lung Disease a Review on the Role of Renin–Angiotensin System and the Angiotensin Converting Enzyme-2

  2020cites this paper
• Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management

  2020cites this paper
• What could explain the late emergence of COVID-19 in Africa?

  2020cites this paper
• The Controversy on the Role of ACE2 Receptor in COVID-19 Infection: The Protective Shift toward the ACE2 Axis

  2020cites this paper